Comparative activity of idarubicin and idarubicinol in combination with cyclosporin A in multidrug resistant leukemia cells

Cancer Chemotherapy and Pharmacology

Volumn 39, Issue 1-2, 1996, Pages 157-161

  Tolomeo, Manlio ^a   Gancitano, Rosa Alba ^a   Musso, Maurizio ^a   Porretto, Ferdinando ^a   Perricone, Rosanna ^a   Abbadessa, Vincenzo ^a   Cajozzo, Aurelio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cyclosporin A; Idarubicin; Idarubicinol; Multidrug resistance

Indexed keywords

CYCLOSPORIN A; IDARUBICIN; IDARUBICINOL;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; CYTOTOXICITY; DRUG UPTAKE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOSPORINE; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; FLOW CYTOMETRY; IDARUBICIN; IMMUNOSUPPRESSIVE AGENTS; TUMOR CELLS, CULTURED;

EID: 0029839620     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050552     Document Type: Article

References (21)

1. Baer MR, Christiansen NP, Frankel SR, Brunetto VL, Mròzek K, Bloomfield CD, Herzig GP (1993) High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia Semin Oncol 6 [Suppl 8]:6
2. Berman E, Heller G, Santorsa J, Meckenzie S, Gee TS, Kempin S, Gulati S, Andreeff M, Kolitz J, Gabrilove J, Reich L, Mayer K. Keefe DF, Trainor K, Schluger A, Penenberg D, Raymond V, O'Reilly R, Jhanwar S, Young C, Clarkson B (1991) Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorbuicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood 77:1666
3. Carella AM, Santini G, Martinengo M, et al (1985) 4-Demethoxydaunorubicin in refractory or relapsed acute leukemias. A pilot study. Cancer 55:1452
4. Daghestani AN, Arlin ZA, Leyland-Jones B, Gee TS, Kempin SJ, Mertelsmann R, Budman D, Schulman P, Baratz R, Williams L, Clarksom BD, Young CW (1985) Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia Cancer Res 45:1408
5. Dodion P, Sanders C, Rombaut W, Mattelaer MA, Rozencweig M, Stryckmans P, Kenis Y (1987) Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitro. Eur J Clin Oncol 23:909
6. Facchetti I, Grandi M, Cucchi P, Geroni C, Penco S, Vigevani A (1991) Influence of lipophilicity on cytotoxicity of anthracyclines in LoVo and LoVo/Dx human cell lines. Anticancer Drug Des 6:385
7. Hindenburg AA, Gervasoni JE, Krishana S, Stewart VJ, Rosado M, Lutzky J, Bhalla K, Baker MA, Taub RN (1989) Intracellular distribution and pharmacokinetics of daunorubicin in anthracycline-sensitive and -resistant HL-60 cells. Cancer Res 49:4607
8. Hu XF, Martin TJ, Bell DR, Luise M, de Zalcberg JR (1990) Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. Cancer Res 50:2953
9. Kuffel MJ, Reid JM, Ames MM (1992) Anthracyclines and their C-13 alcohol metabolites: growth inhibition and DNA damage following incubation with human tumor cells in culture. Cancer Chemother Pharmacol 30:51
10. Lum BL, Kaubisch S, Yahanda AM, et al (1992) Alteration of etoposide pharmacokineics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance. J Clin Oncol 10:1635
11. Nooter K, Oostrum R, Jonker R, Dekken H, Stokdijk W, Engh G (1989) Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 cells measured by real-time flow cytometry. Cancer Chemother Pharmacol 23:296
12. Petrini M, Mattii L, Valentini P, Sabbatini ARM, Grassi B, Grandi M (1993) idarubicin is active on MDR cells: evaluation of DNA synthesis inhibition on P388 cell lines. Ann Hematol 67:227
13. Rassman SMB, Turker A, Powles RL, Smith AG, Newland AC, Erskine JG, Pearce RM, Goldstone AH (1993) Idarubicin for remission induction of acute myeloid leukemia: United Kingdom multicenter experience. Semin Oncol 6 [Suppl 8]:13
14. Reid JM, Pendergrass TW Krailo MD, Hammond GD, Ames MM (1990) Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients. Cancer Res 50:6525
15. Schott B, Robert J (1989) Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and resistant rat glioblastoma cells. Biochem Pharmacol 38:167
16. Schuurhuis GJ, Broxterman HI, Cervantes A, Heijningen THM van, Lange JHM, de Baak JPA, Pinedo HM, Lankelma J (1989) Quantitative determination of factors contributing to doxorubicin resistance in multidrug-resistant cells. J Natl Cancer Inst 81:1887
17. Speth PAJ, Loo FAJ, van de Linssen PCM, Wessels HMC, Haanen C (1986) Plasma and human leukemic cell pharmacokinetics of oral and intravenous 4-demethoxydaunomycin Clin Pharmacol Ther 40:643
18. Tolomeo M, Luparello M, Caravello E, Perricone R, Abbadessa V, Cajozzo A (1991) Effects of epirubicin and idarubicin in multidrug resistant (MDR) Friend leukemia cells (abstract). Proceedings, 11th meeting of the international Society of Haematology-European and African Division, Basel, August 31-September 6, p 137
19. Twentyman PR, Fox NE, White DJG (1987) Cyclosporin A and its analogues as modifiers of Adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line. Br J Cancer 56:55
20. Vogler WR, Velez-Garcia E, Weiner RS, et al (1992) A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeasten Cancer Study Group study J Clin Oncol 10:1103
21. Yahanda AM, Adler KM, Fisher GA, Brophy NA, Halsey J, Hardy RI, Gosland MP, Lum BL, Sikic BI (1992) Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance. J Clin Oncol 10:1624